This web page was produced as an assignment for an undergraduate course at Davidson College.
|
| sources |
This web page was produced as an assignment for an undergraduate course at Davidson College. |
Doeberitz, M.vK. (2006). The dawn of prophylactic vaccines against human papillomavirus and cervical cancer. Int. J Cancer. 119: xi-xii. Doorbar, J. (2005). The papillomavirus life cycle. J Clin. Virol. 32:S7-15. Evans, C.H., Flugelman, A.A., DiPaolo, J.A. (1993). Cytokine modulation of immune defenses in cervical cancer. Oncology. 50:245-51. Guess, J.C., McCance, D.J. (2005). Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to macrophage inflammatory protein-3α production. J Virol. 79:14852-14862. Jansen, K.U., Shaw, A.R. (2004). Human papillomavirus vaccines and prevention of cervical cancer. Annu. Rev. Med. 55:319-31. Oldak, M., Majewski, S., Grzela, T., Stark, S., Malejczyk, M., Osiecka-Iwan, A., Fuchs, P.G., Jablonska, S., Pfister, H.J., Malejczyk, J. (2004). Natural cell-mediated cytotoxicity of peripheral blood lymphocytes against target cells transfected with epidermodysplasia verruciformis-specific human papillomavirus type 8 L1 DNA sequences. Int J Mol Med. 13:187-91. Scott, M., Nakagawa, M., and Moscicki, A.B. (2001). Cell-mediated immune response to human papillomavirus infection. Clin. Diagn. Lab. Immunol. 8:209–220. Stanley, M. (2006). Immune response to human papillomavirus. Vaccine. 24S1:S1/16-22. Stoppler, M.C. “Human Papillomaviruses (HPVs) and Genital Warts.” J.W. Marks, ed. MedicineNet. 22 Aug. 2006. 12 Apr. 2007 <http://www.medicinenet.com/ genital_warts_in_women/article.htm>. Tay, S.K., Jenkins, D., Singer, A. (1987). Natural killer cells in cervical intraepithelial neoplasia and human papillomavirus infection. Br J Obstet Gynaecol. 94:901-6. Woodworth, C.D. (2002). HPV innate immunity. Front Biosci. 7:d2058-71. |
© Copyright 2006 Department of Biology, Davidson College, Davidson, NC 28035 |